Cytocore Inc Receivables Turnover Ratio (CYOE), from the third quarter 2014 to the third quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cytocore Inc  (CYOE)
 

Cytocore Inc Accounts Receivables Turnover Ratio from the third quarter 2014 to the third quarter 2013

Quarterly Results, Trends, Rankings, Statistics


Cytocore Inc's ability to collect accounts receivable sequentially worsen to 7.15, indicating more challenging environment then in the second quarter 2014, but still, it is a far cry from any concerns. Cytocore Inc's Accounts Receivable average collection period in the Sep 30 2014 quarter, has increased to 51 days, from 37 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 206 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 1781 to 2459.

What is Receivable Turnover Ratio?
What is Cytocore Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYOE Receivables Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Receivable Change 15611.11 % 14123.08 % -68 % 1089.55 % -94.61 %
Y / Y Revenue Change 6.22 % 19.09 % 24754.55 % -42.86 % 4198.36 %
Receivable Turnover Ratio (TTM) 7.15 9.87 19.77 12.93 117.26
CYOE's Total Ranking # 2459 # 1781 # 1780 # 1780 # 1780
Accounts Receivable average collection period days 51 37 18 28 3
Seq. Receivable Change -23.53 % 23012.5 % -99.5 % 17611.11 % -30.77 %
Seq. Revenue Change -12.28 % 16.13 % 68250 % -99.85 % -1.65 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 15
Healthcare Sector # 207
Overall Market # 2459

Receivable Turnover Ratio Statistics
High Average Low
0.76 0.52 0.24
(Mar 31 2013)   (Sep 30 2013)





CYOE Company Profile • Back to CYOE Efficiency Comparisons • Compare CYOE Receivables Turnover Ratio to its Competitors

Financial Statements
Cytocore Inc's Accounts Receivable $ 1 Millions Visit CYOE's Balance sheet
Cytocore Inc's Sales TTM $ 9 Millions Visit CYOE's Income Statement
Sources of CYOE's Revenues Visit CYOE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CYOE's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CYOE's Growth Rates CYOE's Roa CYOE's Inventory Turnover Ratio CYOE's Dividend Comparisons
CYOE's Profitability Ratios CYOE's Roi CYOE's Asset Turnover Ratio CYOE's Dividend Growth
CYOE's Valuation Ratios CYOE's Roe CYOE's Financial Strength Ratios CYOE's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Receivable at quarter ending Sep 30 2014
Pacific Biosciences Of California Inc   16.57 $ 52.824  Millions$ 3.189  Millions
International Stem Cell Corporation  16.54 $ 6.935  Millions$ 0.419  Millions
Nektar Therapeutics  15.96 $ 212.301  Millions$ 13.301  Millions
Assertio Holdings inc   15.39 $ 236.369  Millions$ 15.357  Millions
Integrated Biopharma Inc  15.20 $ 33.074  Millions$ 2.176  Millions
Lifeloc Technologies Inc   14.80 $ 8.939  Millions$ 0.604  Millions
Cyclo Therapeutics Inc   14.58 $ 1.356  Millions$ 0.093  Millions
Adma Biologics Inc   14.49 $ 6.701  Millions$ 0.463  Millions
Magellan Health inc   14.48 $ 3,785.869  Millions$ 261.376  Millions
Aveo Pharmaceuticals Inc   14.29 $ 18.331  Millions$ 1.283  Millions
Ligand Pharmaceuticals Incorporated  14.21 $ 56.276  Millions$ 3.960  Millions
Asensus Surgical Inc   14.11 $ 1.319  Millions$ 0.094  Millions
Davita Inc   13.55 $ 20,250.401  Millions$ 1,494.654  Millions
Acorda Therapeutics Inc   13.45 $ 376.201  Millions$ 27.967  Millions
Tenet Healthcare Corp  13.40 $ 28,106.000  Millions$ 2,097.000  Millions
Beam Therapeutics Inc   13.22 $ 1,334.647  Millions$ 100.967  Millions
Chemed Corporation  13.19 $ 1,425.475  Millions$ 108.104  Millions
Dyax Corp  12.66 $ 72.554  Millions$ 5.730  Millions
Insite Vision Inc  12.61 $ 8.930  Millions$ 0.708  Millions
Musclepharm Corporation  12.58 $ 182.210  Millions$ 14.485  Millions
Rockwell Medical inc   12.57 $ 53.705  Millions$ 4.272  Millions
Imunon Inc   12.36 $ 0.500  Millions$ 0.040  Millions
Tandem Diabetes Care Inc   12.16 $ 42.079  Millions$ 3.462  Millions
Hca Healthcare Inc   12.12 $ 65,737.000  Millions$ 5,423.250  Millions
Strata Skin Sciences Inc  12.05 $ 0.680  Millions$ 0.056  Millions
Alaunos Therapeutics Inc   11.97 $ 1.233  Millions$ 0.103  Millions
Immucell Corporation  11.86 $ 6.951  Millions$ 0.586  Millions
Apyx Medical Corp  11.86 $ 26.343  Millions$ 2.222  Millions
Noho, Inc.  11.83 $ 1.177  Millions$ 0.100  Millions
Merrimack Pharmaceuticals Inc  11.28 $ 76.674  Millions$ 6.796  Millions

Date modified: 2026-10-07T13:21:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.